Get Metropolis Healthcare with full year of free testing at just ₹4999
Need help? Talk to our expert.
WhatsApp
Triple Marker Test
₹ 3,500
Triple Marker Test
₹ 3,500
Booked 51+ booked in last 3 days

Triple Marker Test

Also Known As :

Report
Report next day 09:00 pm
Fasting
Fasting no
Recommended for
Recommended for female
Maternal screen (Quadruple Marker) - 2nd Trimester (14 to 22.6 weeks), Serum
₹ 3,500

Quadruple marker test is basically a screening blood test that is used to screen pregnant women for potential congenital defects in foetus i.e., neural tube defects, Down syndrome and Trisomy 18 in the unborn child. Primarily four hormones are measured in mother’s blood (thus known as the Quadruple Marker test). This test can be performed any time between 14 to 22.6 weeks of pregnancy.

The quadruple marker test is a blood test used to screen pregnant women for potential congenital disabilities in the foetus. Some common ones are neural tube defects, Trisomy 18 and Down syndrome. The test primarily measures four hormones in the mother’s blood; therefore, it is known as the quadruple marker test. This test can be performed between weeks 14 and 22 of pregnancy.

Written by : Dr. Jasmin Surana, M.D Biochemistry

Frequently asked questions

Find quick answers to the most common questions about health tests, bookings, and reports.

Quadruple marker test is done to screen genetic disorders and other abnormalities in the fetus. It is very important to know that this is a SCREENING test and a positive (high risk) result does not confirm a defect. Further confirmatory tests should be done to reach a conclusion. Quadruple marker screen can predict approximately 75%-80% of open neural tube defects and can predict approximately 75% of Down syndrome cases in women under age 35 and over 80% of Down syndrome cases in women age 35 years and older. To increase sensitivity NIPT can be offered to patients. This test is also advised if the pregnant women is diabetic or has a family history of congenital disabilities.

This test measuresfour markers (AFP, HCG, estriol & Inhibin-A) in the maternal blood.  This screening test provides statistical examination of patient’s data which includes the biochemical (laboratory) and demographical (statistical study of populations) data. The results are shown in the form of a graph in the test report. The chances of having a baby with Down syndrome or Trisomy 18 depend on multiple factors such as age & body weight of pregnant women, diabetic status & ethnicity etc. The quadruple screen can have false-negative and false-positive results (although it is slightly more accurate than the triple screen)

This test requires a blood sample. A tourniquet (elastic) band is placed tightly on the upper arm. The patient is then asked to make a fist. This helps in the build-up of blood filling the veins. The skin is disinfected before needle insertion and the blood sample is collected in vacutainer

Abnormal test (high risk pregnancy) result does not always indicate a birth defect; it might be because of a variation in the estimated gestational age or other factors. A more specific screening test (NIPT)/ confirmatory test like karyotyping/ FISH are highly recommended.
High levels of AFP point to neural tube defects in the fetus or there can be incomplete closure of the fetus abdomen. 
Low levels of HCG indicate a miscarriage or ectopic pregnancy. Whereas, if the levels of HCG are high this indicates multiple pregnancies. 
Low levels of estriol indicates a high risk with Down syndrome especially when the levels of AFP are low and HCG & Inhibin A are high. A negative screen doesn't guarantee that the baby won't have a chromosomal abnormality, single-gene disorder or certain birth defects. It is always suggested to consult your gynaecologist for any queries.

Book a Home Visit Now

Book any blood test or health checkup and get tested at the comfort of your home.

Why Metropolis Healthcare?

Metropolis has been present for over 43 years in the market.

Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.

NABL & CAP

Accredited labs

Advanced Labs

210+

Advanced Labs

Trusted by

750+ Cities

Global Presence

Scientific Officers

2,000+

Scientific Officers

Proficiency Testing

4,100+

Test & Profiles

Latest Blogs & News

Stay informed with our expert insights and updates.

About Us

Metropolis Healthcare is a leading diagnostic service provider in India. We are a team of dedicated professionals committed to ensuring you and your family receive the most accurate and timely healthcare solutions. We believe in making health care accessible, affordable and evidence-based. Our expert panel are equipped with the latest technology and manned by a certified team of over 4000+ technicians.

In diagnostic services, we have more than three decades of experience servicing diverse stakeholders health advantage packages for men, women and seniors, genetic fitness & corporation in over 650+ tests like Oncology, Neurology, Gynaecology, Haematology, and many more. Our diagnostic services are located in leading doctors and clinics and serve over 15+ cities in India.

Do you have any queries? Or call us now at 0804-8911-400

Proceed
0 items
0
Go to Cart